Skip to content

REDDILab

About

Cutting-Edge Solution

Clemson Continues to Lead

The REDDI Lab is home to Clemson University’s first high complexity Clinical Laboratory Improvement Amendments (CLIA) certified facility (ID: 42D2193465).

Established in Fall 2020, the Clemson University Research and Education in Disease Diagnosis and Intervention (REDDI) Lab was founded by Dr. Delphine Dean in response to the COVID-19 global pandemic.

The University received $6.9 million through the State to assist in developing and expanding the CLIA Lab. The expansion was a multidisciplinary, university-wide effort to create a lab that was a cutting-edge solution to help fight COVID-19. 

The REDDI lab is ready to look past the COVID-19 pandemic and tackle new and existing challenges at the local and global levels.

Mission and Goals

The mission of the REDDI Lab is to operate as a high complexity public health laboratory for upstate South Carolina and design and produce deployable diagnostics, therapeutics, and screening systems for remote communities.

Supporting COVID Research
test samples being handed out
Community testing site